-+ 0.00%
-+ 0.00%
-+ 0.00%

JP Morgan Maintains Neutral on Surgery Partners, Raises Price Target to $15

Benzinga·09/14/2026 12:39:35
Listen to the news
JP Morgan analyst Benjamin Rossi maintains Surgery Partners (NASDAQ:SGRY) with a Neutral and raises the price target from $14 to $15.